ALB and Cirrhosis: After adjusting for potential confounders, admission serum albumin ≤2.4 mg/dL were associated with an increased risk of HAKI in patients with cirrhosis with adjusted OR of 2.60 (95% CI 1.32–5.21) (Table 4).